You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Sanara MedTech Inc. sold all assets of Tissue Health Plus, LLC on October 6, 2026, including its business software products and related intellectual property, to an unrelated third party for approximately $2,000,000 and certain earnout rights.
Sanara MedTech and MiMedx each received an FTC Second Request on October 15, 2026 regarding their pending merger, extending the HSR Act waiting period until 30 days after substantial compliance.
Sanara shareholders approved the merger arrangement under which it would become a wholly-owned subsidiary of MiMedx Group, Inc., and approved related executive-officer compensation. The HSR Act waiting period is scheduled to expire at 11:59 p.m. Eastern Time on October 15, 2026.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $9.3M | First six months of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMTI
this stock
Sanara MedTech Inc.
|
$289.10M | +35.1% | +32.5% | — | 4.1% |
|
ISRG
Intuitive Surgical Inc
|
$162.41B | -20.1% | +20.5% | 56.8 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$57.71B | — | +8.2% | 93.8 | 3.3% |
|
MDLN
Medline Inc.
|
$52.30B | -5.6% | +11.5% | — | 3.1% |
|
ALC
Alcon Inc
|
$36.23B | -4.9% | +10.5% | — | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Sanara MedTech Inc. sold all assets of Tissue Health Plus, LLC on October 6, 2026, including its business software products and related intellectual property, to an unrelated third party for approximately $2,000,000 and certain earnout rights.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMTI | -3.9% | -10.0% | +44.1% | -3.9% | +35.1% |
| SPY | -2.7% | -5.6% | -0.5% | -2.7% | +7.8% |
| vs SPY | -1.2% | -4.5% | +44.6% | -1.2% | +27.3% |
